Overview

Biosoft aims to become a conductor between fundamental science and services. It helps business representatives to find appropriate scientific partners.

img

VISION AND MISSION

Biosoft aims to put on stream fundamental science problems that phramaceutical and other lifesciences companies are forced to deal with in order to get a desired result.

img

Certifications

The BioUML platform is certified and intellectual rights on it totally belong to the Biosoft company

img

Quality

Biosoft is totally responsible for the quality of all of the services it provides.

img

Top management

Our top management team unites experts in science and administration, that's why Biosoft is developing quickly and efficiently.

img

Scientific advisers

Biosoft has collected a team of real experts to grant you top quality scientific services.

img

News

The workflow system "From genome to target" is coming up this summer

Track the news on our web site as we have almost started the countdown to the very first public release of our workflow system "From genome to target" for automatized search of new therapeutic targets.

6 June 2017
Biosoft is opening a new office in Skolkovo Technopark

Come and join us on the grand opening of Biosoft's new office in Skolkovo Technopark on April 21st! You will find interesting lectures on bioinformatics, workshops and a hakaton on search for personalized biomarkers and drug targets on real patient's data.

5 April 2017
Webinar on discovery of new biomarkers and drug targets

Join us on April 13th if you are interested in molecular medicine and drug development, as we are going to give a webinar on the basic approach for searching for new drug targets and biomarkers.

5 April 2017

Biosoft owns all the rights on the BioUML platform for biomedical data analysis. The intellectual property is guarded by the certificate of computer program registration, issued on 19th of June 2008 in Novosibirsk, Russia.